Erwin Cary Goldberg

US Patent:

47821361, Nov 1, 1988

Filed:

Dec 1, 1986

Appl. No.:

6/936170

Inventors:

Erwin Goldberg - Evanston IL
Jose L. Millan - San Diego CA

Assignee:

Northwestern University - Evanston IL

International Classification:

C07K 708
C07K 706
C07K 710

US Classification:

530326

Abstract:

Synthetic peptide compounds are provided which are capable of producing antibodies binding to the lactate dehydrogenase enzyme of human serum (LDH-C. sub. 4). The peptide compounds comprise antigenic sequences of human LDH-C. sub. 4. The peptide compounds can be used to prepare vaccines for reducing the fertility of women.

US Patent:

45855870, Apr 29, 1986

Filed:

Oct 19, 1984

Appl. No.:

6/663057

Inventors:

Erwin Goldberg - Evanston IL
Thomas E. Wheat - Chicago IL

Assignee:

Northwestern University - Evanston IL

International Classification:

C07C10352

US Classification:

2601125R

Abstract:

The novel antigenic linear peptides of this invention comprise peptides of from 4 to 13 amino acids, which are characterized by containing the sequence valine-leucine-aspartic acid-methionine. These compounds correspond with the amino acids 231 to 243, or segments thereof including sequence 239-242 of mouse LDH-C. sub. 4. The coupounds have utility in vaccines for reducing the fertility of female mammals.

US Patent:

43549675, Oct 19, 1982

Filed:

Jun 26, 1981

Appl. No.:

6/277623

Inventors:

Erwin Goldberg - Evanston IL

Assignee:

Northwestern University - Evanston IL

International Classification:

C07C10352

US Classification:

2601125R

Abstract:

The novel antigenic linear peptide compound of this invention comprises a sequence of ten amino acids namely, serine-leucine-asparagine-proline-alanine-isoleucine-glycine-threonine-asp artic acid-lysine, all of the amino acids being in their L-forms with the exception of glycine. The compound has utility in vaccines for reducing the fertility of mammals.

US Patent:

43775160, Mar 22, 1983

Filed:

Dec 10, 1981

Appl. No.:

6/329242

Inventors:

Erwin Goldberg - Evanston IL

Assignee:

Northwestern University - Evanston IL

International Classification:

C07C10352

US Classification:

2601125R

Abstract:

The novel antigenic linear peptide compounds of this invention comprise sequences of from 10 to 14 amino acids which include the sequence arginine-methionine-valine-serine-glycine-glutamine-threonine-arginine-leu cine-aspartic acid, all of the amino acids with the exception of glycine being in their L-forms. The compounds have utility in vaccines for reducing fertility of mammals.

US Patent:

45782199, Mar 25, 1986

Filed:

Oct 19, 1984

Appl. No.:

6/663058

Inventors:

Erwin Goldberg - Evanston IL
Thomas E. Wheat - Chicago IL

Assignee:

Northwestern University - Evanston IL

International Classification:

C07C10352

US Classification:

2601125R

Abstract:

The novel antigenic linear peptide of this invention comprise a linear peptide of 13 amino acids, comprising the sequence Val-Asn-Met-Thr-Ala-Gly-Glu-Glu-Gly-Leu-Leu-Lys-Lys. This compound corresponds with the amino acids 304 to 316 of mouse LDH-C. sub. 4. The compound has utility in vaccines for reducing the fertility of female mammals.

US Patent:

43104568, Jan 12, 1982

Filed:

Aug 18, 1980

Appl. No.:

6/179049

Inventors:

Erwin Goldberg - Evanston IL

Assignee:

Northwestern University - Evanston IL

International Classification:

C07C10352

US Classification:

2601125R

Abstract:

The novel antigenic linear peptide compound of this invention comprises a sequence of nine amino acids; namely, arginine-methionine-valine-serine-glycine-glutaminethreonine-arginine-leuc ine, all of the amino acids with the exception of glycine being in their L-forms. The compound has utility in vaccines for reducing fertility of mammals.

US Patent:

43929974, Jul 12, 1983

Filed:

Jun 16, 1982

Appl. No.:

6/389040

Inventors:

Erwin Goldberg - Evanston IL

Assignee:

Northwestern University - Evanston IL

International Classification:

C07C10352

US Classification:

2601125R

Abstract:

The novel antigenic peptide compounds of this invention comprise sequences of 12 to 19 amino acids, which include twelve amino acid sequence glutamic acid-glutamine-leucine-isoleucine-glutamine-asparagine-leucine-valine-prol ine-glutamic acid-aspartic acid-lysine, all of the amino acids being in their L-forms. The compounds have utility in vaccines for reducing the fertility of mammals.

US Patent:

43538223, Oct 12, 1982

Filed:

May 26, 1981

Appl. No.:

6/267021

Inventors:

Erwin Goldberg - Evanston IL

Assignee:

Northwestern University - Evanston IL

International Classification:

C07C10352

US Classification:

2601125R

Abstract:

The novel antigenic linear peptide compounds of this invention are characterized by providing a sequence of eight amino acids comprising isoleucine-serine-glycine-phenylalanine-proline-valine-glycine-arginine, all of the amino acids with the exception of glycine being in their L-forms. The isoleucine may comprise the N-terminal end or may be bonded to N-terminal glycine, and the arginine may be the C-terminal amino acid or may be bonded to C-terminal valine. The compounds have utility in vaccines for reducing the fertility of mammals.